Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by icecubeon Sep 30, 2015 12:14am

34 Views

Post# 24147966

RE:RE:RE:RE:RE:RE:RE:RE:Caution

truthseeker2012 wrote: Things have changed since then haven't they. I trusted the CEO he was doing well & he isn't doing well now. Well good for him bad for everyone else.

You did not predict fraud & you still can't recognize it now dope. I can change my opinion based upon facts. I still made good $ but I wanted more. I'll get more out of your own wallet when a_holes like you are crushed in the coming stock market apocalypse. You will be destroyed as you deserve. Karma I love it!!

Show proof of fraud otherwise please ask your parents to help you to get back onto your meds.

Bullboard Posts

Opawica seeks drill permits for Bazooka Gold Targets in Abitibi